REV 15 mg (Revlimid 15 mg)

Generic Name: lenalidomide

Pill imprint REV 15 mg has been identified as Revlimid 15 mg.

Revlimid is used in the treatment of multiple myeloma; mantle cell lymphoma; anemia and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for REV 15 mg

Revlimid
Generic Name:
lenalidomide
Imprint:
REV
15 mg
Strength:
15 mg
Color:
Blue & White
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antineoplastics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Celgene Corporation
National Drug Code (NDC):
59572-0415
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
croscarmellose sodium
magnesium stearate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)